We further detected the endogenous expression levels of IGF2BP2, OIP5-AS1, and miR-495-3p in both glioma tissues and cells, and further explored the mutual regulatory mechanism between these molecules and their effects on VM capacity of glioma cells. Here, IGF2BP2 is linked to central nervous system cancer.